<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dori D</submitter><funding>the Canadian Institutes of Health Research</funding><pagination>e70960</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12706624</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(12)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Controversial hypotheses suggest that "suboptimal" thyroid function - defined as higher-normal thyroid-stimulating hormone (TSH) (2.0 to 4.5 μIU/mL) or low-normal free thyroxine (FT4) - may increase risk of cognitive decline and dementia in older patients.&lt;h4>Methods&lt;/h4>We examined this claim using data from the Canadian Comprehensive Assessment of Neurodegeneration and Dementia cohort (ages 50 to 91; cognitive statuses from unimpaired to dementia, rarer subtypes of dementia excluded). Thyroid function was categorized as "optimal" (TSH &lt; 2.0 μIU/mL or FT4 ≥ 16.74 pmol/L) or "suboptimal." Six hundred eighty-eight participants had TSH data, and 476 participants had FT4 data.&lt;h4>Results&lt;/h4>Chi-squared analyses showed no significant association between "suboptimal" thyro</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.</pubmed_title><pmcid>PMC12706624</pmcid><funding_grant_id>CNA-163902</funding_grant_id><funding_grant_id>CNA-137794</funding_grant_id><funding_grant_id>BDO-148341</funding_grant_id><pubmed_authors>Chertkow H</pubmed_authors><pubmed_authors>Borrie M</pubmed_authors><pubmed_authors>Seixas-Lima B</pubmed_authors><pubmed_authors>Lahiri D</pubmed_authors><pubmed_authors>Roncero C</pubmed_authors><pubmed_authors>Dori D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.</name><description>&lt;h4>Introduction&lt;/h4>Controversial hypotheses suggest that "suboptimal" thyroid function - defined as higher-normal thyroid-stimulating hormone (TSH) (2.0 to 4.5 μIU/mL) or low-normal free thyroxine (FT4) - may increase risk of cognitive decline and dementia in older patients.&lt;h4>Methods&lt;/h4>We examined this claim using data from the Canadian Comprehensive Assessment of Neurodegeneration and Dementia cohort (ages 50 to 91; cognitive statuses from unimpaired to dementia, rarer subtypes of dementia excluded). Thyroid function was categorized as "optimal" (TSH &lt; 2.0 μIU/mL or FT4 ≥ 16.74 pmol/L) or "suboptimal." Six hundred eighty-eight participants had TSH data, and 476 participants had FT4 data.&lt;h4>Results&lt;/h4>Chi-squared analyses showed no significant association between "suboptimal" thyro</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-07T05:21:34.815Z</modification><creation>2026-06-07T03:07:12.216Z</creation></dates><accession>S-EPMC12706624</accession><cross_references><pubmed>41400007</pubmed><doi>10.1002/alz.70960</doi></cross_references></HashMap>